SCHEMBL127656

SCHEMBL127656

COc1c(CO)ccc2cc(-c3cc4c(c(-c5ccc(-c6ccccc6)cc5)c3)OCO4)[n+](C)cc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.38
CYP1B1 Q16678 2/20 0.38
BCHE P06276 6/20 0.38
PREP P48147 2/20 0.38
ALDH1A1 P00352 4/20 0.37
MAPT P10636 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
KMT2A Q03164 3/20 0.37
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 3/20 0.37
TSHR P16473 3/20 0.37
MEN1 O00255 2/20 0.37
CYP1A2 P05177 2/20 0.37
HIF1A Q16665 2/20 0.37
HPGD P15428 2/20 0.37
MAPK1 P28482 2/20 0.37
ATP2A1 O14983 1/20 0.37
NPC1 O15118 1/20 0.37
USP2 O75604 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16189646 0.89 BCHE (0.48) ACHECYP1B1BCHEPREPALDH1A1
SCHEMBL129768 0.83 PTGS1 (0.44) ACHECYP1B1BCHEPREPALDH1A1
SCHEMBL128827 0.81 CYP1B1 (0.40) ACHECYP1B1BCHEPREPALDH1A1
SCHEMBL128821 0.78 CYP3A4 (0.39) ACHECYP1B1BCHEPREPALDH1A1
SCHEMBL129789 0.77 CYP1B1 (0.47) ACHECYP1B1BCHEPREPALDH1A1
SCHEMBL128820 0.74 TARBP2 (0.35) ACHEBCHEPREPMAPTCYP3A4
SCHEMBL129785 0.74 ACHE (0.43) ACHECYP1B1BCHEPREPALDH1A1
SCHEMBL10132426 0.74 ALDH1A1 (0.50) ACHEBCHEALDH1A1MAPTSMN1; SMN2
SCHEMBL10132417 0.73 ALDH1A1 (0.49) ACHEBCHEALDH1A1MAPTSMN1; SMN2
SCHEMBL10132415 0.73 ALDH1A1 (0.54) ACHECYP1B1BCHEPREPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9227966-B2 Antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-01-05 US disclosed
US-20140315939-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-10-23 US disclosed
US-20120059026-A1 ANTIMICROBIAL AGENTS UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059026-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L ACHE 3213/4885CYP1B1 531/4885BCHE 2274/4885
US-20140315939-A1 ANTIMICROBIAL AGENTS ZYX, Q6ZSR9, ZC3HAV1L ACHE 3734/4885CYP1B1 715/4885BCHE 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.